Helen Raynham, MD
MOHS-Micrographic Surgery · Natick, MANPI 1467423541
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $5,250 of the $7,408 with a category attached, or 70.9%. Surgical Specialties Corporation (US), Inc. (dba Corza Medical) accounts for 72.7% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2020 at $4,045 and has fallen 73.8% since, to $1,058 in 2025.
Across 89 payments — averaging $83.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Surgical Specialties Corporation (US), Inc. (dba Corza Medical)$5K
- AbbVie$436
- Johnson & Johnson$419
- Lilly USA, LLC$174
- Novartis$139
- E.r. Squibb & Sons, L.L.C.$128
- plus $727 from 11 others
What the payments were for
- Consulting fees$5,25071%
- Food & beverage$2,15829%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Surgical Specialties Corporation (US), Inc. (dba Corza Medical) | 6 | $5,384 |
| AbbVie | 19 | $436 |
| Johnson & Johnson | 15 | $419 |
| Lilly USA, LLC | 8 | $174 |
| Novartis | 6 | $139 |
| E.r. Squibb & Sons, L.L.C. | 5 | $128 |
| LEO Pharma Inc. | 5 | $117 |
| Amgen | 4 | $107 |
| Sanofi | 3 | $96 |
| Organon | 3 | $85 |
| Sun Pharmaceutical Industries Inc. | 4 | $85 |
| UCB, Inc. | 3 | $78 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $63 |
| Mimedx Group, Inc. | 2 | $33 |
| Incyte Corporation | 1 | $25 |
| Galderma Laboratories, L.p. | 1 | $22 |
| Biofrontera Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,408 in reported general payments places this provider in the 85th percentile of 38 mohs-micrographic surgery providers in Massachusetts.
See all mohs-micrographic surgery providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 14 | $1,172 |
| Mupirocin | 164 | $1,060 |
| Gentamicin Sulfate | 22 | $911 |
| Ketoconazole | 23 | $487 |
| Fluocinolone Acetonide | 11 | $373 |
| Triamcinolone Acetonide | 20 | $295 |
| Cephalexin | 50 | $261 |
| Hydrocortisone | 17 | $98 |
| Lorazepam | 16 | $8 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Natick
- Chrysalyne SchmultsJamaica Plain$58K
- Suzanne OlbrichtBurlington$12K
- Sameer GuptaBoston$11K
- Thomas RohrerChestnut Hill$9K
- Omar BadriBeverly$7K
- Benjamin SolkyBoston$7K
- Carin LitaniWellesley Hills$5K
- Christine KannlerBeverly$4K
- Niels KrejciNorwood$4K
- Jonathan WeissBoston$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.